期刊文献+

Wnt5a结肠腺瘤性息肉病基因和β-连环素在结直肠腺癌组织中的表达和意义 被引量:6

Expression of Wnt5a, APC,β-catenin and their clinical significance in human colorectal adenocarcinoma
原文传递
导出
摘要 目的探讨Wnt5amRNA和蛋白、结肠腺瘤性息肉病基因(APC)和B-连环素(B—catenin)蛋白在结直肠腺癌组织中的表达及意义。方法应用实时定量PCR法,检测30例新鲜结直肠腺癌组织和配对的痛旁组织中Wnt5amRNA的表达。采用免疫组织化学sP法,检测62例结直肠腺癌和癌旁组织以及10例正常结直肠黏膜组织中Wnt5a、APC和B—catenin蛋白的表达情况,并分析Wnt5a、APC和B.catenin蛋白的表达与结直肠腺癌患者临床病理特征的关系。结果Wnt5amRNA在新鲜结直肠腺癌组织中的相对表达量为0.1232±0.0140,明显高于其在癌旁结直肠黏膜组织中的相对表达量(0.0497±0.0074,P=0.02)。Wnt5a蛋白在61.3%(38/62)的结直肠腺癌组织中低表达,在38.7%(24/62)的结直肠腺癌组织中高表达,其表达与肿瘤的组织学类型和分化程度有关(均P〈0.05)。APC蛋白住61.3%(38/62)的结直肠腺癌组织中低表达,其表达与肿瘤的组织学分犁有关(P〈0.05)。B—catenin蛋白在80.6%(50/62)的结直肠腺癌组织中呈胞质和(或)胞核的异位表达,其表达与肿瘤的分化程度、有无淋巴结转移、浸润深度以及TNM分期均有关(均P〈0.05)。在结直肠腺癌组织中,Wnt5a(r=0.271,P=0.027)和APC(r=0.343,P=0.004)蛋白的低表达均与B—catenin蛋白的异位表达相关,仉Wnt5a与APC蛋白的表达无关(r=0.218,P=0.078)。结论Wnt5a、APC和B—catenin基因可能参与了结直肠腺癌的发生和发展过程。在结直肠腺癌中,APC和Wnt5a蛋白的低表达可能是B-catenin蛋白异位表达的原因之一。 Objective To study the expression of WntSa gene mRNA and WntSa, APC, 13-catenin proteins in human colorectal adenocarcinoma (CRC) and explore its clinical significance. Methods WntSa mRNA level was measured in 30 patients with CRC and paired non-tumor tissues by real-time PCR. Immunohistochemical staining of WntSa, APC, β--catenin was performed in samples of 62 patients with CRC using SP system. Results The relative expression level of WntSa mRNA in fresh CRC is 0. 1232±0.0140, which is significantly higher than that in adjacent colorectal mucosa(0. 0497±0. 0074, P = 0.02). A low expression of WntSa protein was observed in 38 of 62 CRC. WntSa protein expression was closely correlated with the tumor types and the degree of tumor differentiation ( P 〈 0.05 ). There was no apparent relationship with lymph node metastasis, depth of myometrial invasion and TNM stages (P 〉 0.05). APC protein was decreased in 38 of 62 CRC. The expression of APC was closely correlated with the tumor types (P 〈 0.05 ). There was no apparent relationship with the degree of tumor differentiation, lymph node metastasis, depth of myometrial invasion and TNM stages ( P 〉 0.05 ). The expression of β--catenin was observed in cytoplasm and/or cell nuclei in 50 of 62 CRC. The positive rate of β--catenin expression was closely correlated with the degree of tumor differentiation, lymph node metastasis, depth of myometrial invasion and TNM stages ( P 〈 0.05 ). There was no apparent relationship with the tumor types ( P 〉 0.05 ). The expressions of Wnt5 a ( r = 0.271, P = 0. 027 ) and APC ( r = 0. 343, P = 0.004 ) were correlated with that of β--catenin in CRC, respectively, but there was no correlation between the expressions of WntSa and APC protein (r = 0.218, P = 0.078)in the tumors. Conclusions WntSa, APC and β-catenin genes might be involved in the carcinogenesis and development of CRC. It is hypothesized that down-regulation of APC and WntSa proteins may be one of causes of ectopic expression of β-catenin in CRC.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2012年第9期674-678,共5页 Chinese Journal of Oncology
关键词 WNT5A 结肠腺瘤性息肉病基因 Β-连环素 结直肠肿瘤 实时定量PCR WntSa Adenomatous polyposis coli β--catenin Colorectal neoplasms Real-time PCR
  • 相关文献

参考文献13

  • 1Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol, 2004, 20:781-810.
  • 2Hinoi T, Yamamoto H, Kishida M, et al. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta- catenin and down-regulates beta-catenin. J Biol Chem, 2000, 275 : 34399 -34406.
  • 3Kremenevskaja N, von Wasielewski R, Rao AS, et al. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene, 2005, 24:2144-2154.
  • 4Kurayoshi M, Oue N, Yamamoto H, et al. Expression of Wnt-Sa is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res, 2006, 66: 10439- 10448.
  • 5Jtinsson M, Dejmek J, Bendahl PO, et al. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res, 2002, 62:409-416.
  • 6Hoang CL, Liu D, Nakano J, et al. WntSa expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor:an expression in non-small-cell lung cancer. J Clin Oncol, 2005, 23:8765-8773.
  • 7Yuzugullu H, Benhaj K, Ozturk N, et al. Canonical Wnt signaling is antagonized by noncanonical WntSa in hepatocellular carcinoma cells. Mol Cancer, 2009, 8:90.
  • 8I)ejmek J, Dejmek A, ssfholm A, et al. Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res, 2005, 65:9142-9146.
  • 9杨吉龙,王坚,周晓燕,朱雄增.侵袭性纤维瘤病中的APC和β-catenin基因及8号染色体异常[J].中华肿瘤杂志,2008,30(2):116-120. 被引量:7
  • 10赖天霞,苗静琨,何焕玲,左国伟,李星星,王嫣,王胜,何通川,周兰.钙结合蛋白S100A6对Wnt/β-catenin信号途径的影响[J].中华肿瘤杂志,2008,30(1):12-15. 被引量:9

二级参考文献30

  • 1徐建明,朱步东,Mangia Anita,Simone Gianni,Montemurro Severino,Giuliani Francesco,Maiello Evaristo,Colucci Giuseppe,Paradiso Angelo.胸苷酸合成酶和拓扑异构酶-1及Ki-67对伊立替康联合5-氟脲嘧啶治疗晚期大肠癌的预测价值[J].中华肿瘤杂志,2005,27(5):312-315. 被引量:9
  • 2全国大肠癌病理研究协作组.全国大肠癌病理研究统一规范.全国大肠癌美景病理读片会[M].杭州,1982.12-16.
  • 3He TC, Sparks AB, Rago C, et al. Identification of c-Myc as a target of the APC pathway. Science, 1998, 281:1509-1512.
  • 4Zhou L, An N, Haydon RC, et al. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the β-catenin signaling activity. Cancer Lett, 2003, 193:161-170.
  • 5Dihlmann S, von Knebel Doeberitz M. Wnt/β-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer, 2005, 113:515-524.
  • 6Stulik J, Osterreicher J, Koupilova K, et al. Differential expression of the Ca^2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosa. Eur J Cancer, 2000, 36:1050-1059.
  • 7Luu HH, Zhou L, Haydon RC, et al. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett, 2005, 229:135-148.
  • 8Hsieh HL, Schafer BW, Sasaki S, et al. Expression analysis of S100 proteins and RAGE in human tumours using tissue microarrays. Biochem Biophys Res Commun, 2003, 307: 375- 381.
  • 9Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics winggless signaling in intact cells. Curr Biol,1996,6:1664-1668.
  • 10Fukumoto S, Hsieh CM, Maemura K, et al. Akt participation in the Writ signaling pathway through Dishevelled. J Biol Chem, 2001, 276 : 17479-17483.

共引文献37

同被引文献45

  • 1De-Ren Fang,Zhong-Fa Lv,Gang Qiao.Dynamic Wnt5a expression in murine hair follicle cycle and its inhibitory effects on follicular in vivo[J].Asian Pacific Journal of Tropical Medicine,2014,7(4):285-288. 被引量:2
  • 2张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 3Ji JS, Choi KY , Lee WC, et al. Endoscopie and his- topathologic predictors of recurrence of colorectal ade- noma on lowering the miss rate[J]. Korean Journal of Internal Medicine,2009,24(3) :196-202.
  • 4Jacobs ET, Ahnen DJ, Ashbeck EL, et al. Associaton between body mass index and eoloreetal neoplasia at fol- lowup colonoscopy: a poolong study [J]. American Journal of Epidemiology, 2009,169(6):657-666.
  • 5Rapuri S, Spencer J, Eckels D. Importance of post- polypectomy surveillance and postpolypectomy compli- ance to follow-up screening-review of literature[J]. lnt J Colorectal Dis,2008,23(5) :452-459.
  • 6Hong Z Y, Lee H J, Shin D Y, et al. Inhibition of Akt/FOXO3a signaling by constitutively active FOXO3a suppresses growth of follicular thyroid cancer cell lines [ J]. Cancer Lett, 2012,314 (1) :34 -40.
  • 7Lu M, Zhao Y, Xu F, et al. The expression and prognosis of FOXO3a and Skp2 in human ovarian cancer [ J ]. Med Oncol, 2012,29(5) :3409 -15.
  • 8Shiota M, Song Y, Yokomizo A, et al. FOXO3a suppression of urothelial cancer invasiveness through Twistl, Y-box-binding pro- tein 1, and E-cadherin regulation [ J]. Clin Cancer Res, 2010,16 (23) :5654 -63.
  • 9Fang L, Wang H, Zhou L, Yu D. Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOX03 a-targeted gene therapy [ J ]. Oral Oncol, 2011, 47(1) :16 -21.
  • 10Roukos D H, Ziogas D E, Papaloukas C, Bahogiannis G. Novel Wnt signaling and other pathway inhibitors in the colorectal cancer genomic landscape era[J]. Future Oncol, 2012,8( 11 ) :1373 -6.

引证文献6

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部